Unleashing the Power of Fecal Microbiota Transplant: A Comprehensive Quantitative Analysis
Impact of Compounds on Fibroblast-to-Myofibroblast Transition (FMT)
Client Inquiry:
A client wanted to analyze how three compounds affect the fibroblast-to-myofibroblast (FMT) transition and if they possess anti-fibrotic properties. The client needed a supplier for high-content imaging (HCI) to conduct this analysis.
Solution Approach:
-
Understanding the Problem:
Newcells collaborated with the client to grasp their specific needs. The goal was to gain insights into the anti-fibrotic effects of the compounds, focusing on quantitative dose responses and the impact on alpha-smooth muscle actin and extracellular collagen I deposition. -
Study Design:
Newcells developed a protocol for studying the effects of three chemicals on simulated primary lung fibroblasts. The fibroblasts received the compounds before activation with stimuli that imitate fibrotic diseases. HCI was employed to quantify the expressions of extracellular collagen I and alpha-smooth muscle actin. -
Execution and Timeliness:
The study included the experimental phase, data processing, and analysis, culminating in a presentation of findings to the client. The experiment used 384-well plates and assessed immunofluorescence for each data point. This comprehensive investigation involved over 1,000 data points and concluded just over a month after the contract was signed. - Deliverables:
Newcells provided a detailed report containing a reliable dataset, including raw and normalized data, statistical analysis, and representative immunofluorescence images.
Client Outcomes:
Newcells successfully communicated the data findings to the client and delivered a thorough report with all necessary information.
About Newcells Biotech:
Newcells Biotech specializes in developing in vitro cell-based assays for drug and chemical discovery. The company combines expertise in induced pluripotent stem cells (iPSCs), cellular physiology, and organoid technology to create models that predict the in vivo behavior of new drugs. Their assays evaluate transporter function, safety, and efficacy across various cell types, including kidney, retina, and lungs.
Visit Newcells Biotech for more information.